LONDON, United Kingdom (AFP) - British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing (KBP) will launch trials of a potential coronavirus vaccine, developed using tobacco plant technology.The group said the US Food and Drug Administration (FDA) has approved its application for a vaccine candidate, paving the way for an initial phase one clinical trial in 180 adults.
